End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,040 KRW | -1.67% | +15.27% | -12.31% |
May. 13 | HLB Life Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 22 | HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% | MT |
Sales 2022 | 99.59B 71.9M | Sales 2023 | 97.99B 70.75M | Capitalization | 1,166B 842M |
---|---|---|---|---|---|
Net income 2022 | -54.28B -39.19M | Net income 2023 | -5.98B -4.32M | EV / Sales 2022 | 11 x |
Net Debt 2022 | 16.03B 11.58M | Net Debt 2023 | 87.72B 63.33M | EV / Sales 2023 | 12.8 x |
P/E ratio 2022 |
-19.7
x | P/E ratio 2023 |
-195
x | Employees | 110 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.64% |
1 day | -1.67% | ||
1 week | +15.27% | ||
1 month | -41.66% | ||
3 months | -28.74% | ||
6 months | +6.81% | ||
Current year | -12.31% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Ki-Hwan Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | 15-12-10 |
Sang-Woo Nam
CEO | Chief Executive Officer | 66 | - |
Yoon-Gi Baek
BRD | Director/Board Member | 61 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +5.36% | - | |
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 10,040 | -1.67% | 2,357,164 |
24-05-30 | 10,210 | -5.02% | 2,806,803 |
24-05-29 | 10,750 | +7.29% | 4,599,827 |
24-05-28 | 10,020 | +9.15% | 8,348,958 |
24-05-27 | 9,180 | +5.40% | 2,769,932 |
End-of-day quote Korea S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.31% | 781M | |
+23.03% | 74.04B | |
-1.52% | 24.18B | |
+3.67% | 8.46B | |
+8.55% | 8.34B | |
-23.71% | 7.64B | |
+15.20% | 5.33B | |
+2.68% | 4.12B | |
-6.90% | 3.92B | |
+5.56% | 3.89B |
- Stock Market
- Equities
- A067630 Stock